{'fraction_non_alphanumeric': 0.017897091722595078, 'fraction_numerical': 0.0, 'mean_word_length': 4.973333333333334, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Agency Wants to Stop Shopping for Best Deal

CLINICAL TRIALSThe U.S. Food and Drug Administration is worried that clinical researchers might ask safety officials to approve studies involving human subjects that have been rejected by other panels. To deter "IRB shopping," the government has proposed that researchers be required to tell safety panels about any prior reviews. But last week the biomedical community gave the plan a mixed reception.